Dopamine agonist therapy in early Parkinson's disease-Reference-Cited by-同舟云学术

Dopamine agonist therapy in early Parkinson's disease

Published:2008-04-23 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Stowe Rebecca¹,Ives Natalie¹,Clarke Carl E²,van Hilten ³,Ferreira Joaquim⁴,Hawker Robert J¹,Shah Laila¹,Wheatley Keith⁵,Gray Richard⁶

Affiliation:

1. University of Birmingham; University of Birmingham Clinical Trials Unit; Division of Medical Sciences, Robert Aitken Institute Edgbaston Birmingham UK B15 2TT

2. City Hospital, Sandwell and West Birmingham Hospitals NHS Trust; Department of Neurology; Dudley Road Birmingham West Midlands UK B18 7QH

3. Leiden University of Medical Center; Department of Neurology; Albinusdreef 2 Leiden Netherlands 2333 ZA

4. Faculdade de Medicina de Lisboa; Laboratório de Farmacologia Clínica e Terapêutica; Hospital de Santa Maria Av. Prof. Egas Moniz Lisboa Portugal 1649-028

5. Robert Aitken Institute University of Birmingham; Birmingham Clinical Trials Unit - Division of Medical Sciences; Edgbaston Birmingham UK B 15 2 TT

6. The University of Birmingham; Clinical Trials Unit; Park Grange 1 Somerset Road Edgbaston Birmingham UK B15 2RR

Publisher

Wiley

Subject

Pharmacology (medical)

Reference59 articles.

1. Long term bromocriptine treatment in de novo Parkinsonian patients;Herskovits;Medicina (B Aires),1988

2. Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: A two-year follow-up study of previously untreated patients;Kulisevsky;Movement Disorders,2000

3. A double-blind study of bromocriptine and L-dopa in de novo Parkinson's disease. Short-term results;Riopelle;European Neurology,1988

4. Bromocriptine and levodopa in early combination in Parkinson's Disease: first results of the Collaborative European Multicentric Trial;Olsson,1990

5. CQA 206-291: a novel dopamine agonist in the treatment of Parkinson's disease;Rascol;Clinical Neuropharmacology,1990

Cited by 163 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacotherapy of motor symptoms in early and mid-stage Parkinson’s disease: guideline “Parkinson’s disease” of the German Society of Neurology;Journal of Neurology;2024-08-29

2. Non-Ergot Dopamine Agonists and the Risk of Heart Failure and Other Adverse Cardiovascular Reactions in Parkinson’s Disease;Brain Sciences;2024-07-31

3. Dose–response relationship of levodopa with dyskinesia in Parkinson's disease: A systematic review and meta-analysis;Heliyon;2024-03

4. Inhibition of Indirect Pathway Activity Causes Abnormal Decision-Making In a Mouse Model of Impulse Control Disorder in Parkinson’s Disease;2024-02-22

5. Circuit-specific gene therapy reverses core symptoms in a primate Parkinson’s disease model;Cell;2023-11